Sharp T - Search Results

1

Evaluation of the effect of chronic antidepressant treatment on neurokinin-1 receptor expression in the rat brain.

Sartori SB, Burnet PW, Sharp T, Singewald N. Sartori SB, et al. Among authors: sharp t. Neuropharmacology. 2004 Jun;46(8):1177-83. doi: 10.1016/j.neuropharm.2004.02.013. Neuropharmacology. 2004. PMID: 15111024

2

Stereoselective and region-specific induction of immediate early gene expression in rat parietal cortex by blockade of neurokinin 1 receptors.

Serres F, Sartori SB, Halton A, Pei Q, Rochat C, Singewald N, Sharp T, Millan MJ. Serres F, et al. Among authors: sharp t. J Psychopharmacol. 2006 Jul;20(4):570-6. doi: 10.1177/0269881105059327. Epub 2005 Oct 4. J Psychopharmacol. 2006. PMID: 16204322

3

[No title available]

[No authors listed] [No authors listed] PMID: 32585790

4

Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs.

Singewald N, Salchner P, Sharp T. Singewald N, et al. Among authors: sharp t. Biol Psychiatry. 2003 Feb 15;53(4):275-83. doi: 10.1016/s0006-3223(02)01574-3. Biol Psychiatry. 2003. PMID: 12586446

5

Repeated ECS differentially affects rat brain 5-HT1A and 5-HT2A receptor expression.

Burnet PW, Mead A, Eastwood SL, Lacey K, Harrison PJ, Sharp T. Burnet PW, et al. Among authors: sharp t. Neuroreport. 1995 Apr 19;6(6):901-4. doi: 10.1097/00001756-199504190-00019. Neuroreport. 1995. PMID: 7612879

6

Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock.

Burnet PW, Sharp T, LeCorre SM, Harrison PJ. Burnet PW, et al. Among authors: sharp t. Neurosci Lett. 1999 Dec 24;277(2):79-82. doi: 10.1016/s0304-3940(99)00857-5. Neurosci Lett. 1999. PMID: 10624814

7

Electroconvulsive shock increases tachykinin NK(1) receptors, but not the encoding mRNA, in rat cortex.

Burnet PW, Miller R, Lewis LJ, Pei Q, Sharp T, Harrison PJ. Burnet PW, et al. Among authors: sharp t. Eur J Pharmacol. 2001 Feb 16;413(2-3):213-9. doi: 10.1016/s0014-2999(01)00777-4. Eur J Pharmacol. 2001. PMID: 11226395

8

Critical issues in the antisense inhibition of brain gene expression in vivo: experiences targetting the 5-HT1A receptor.

Le Corre SM, Burnet PW, Meller R, Sharp T, Harrison PJ. Le Corre SM, et al. Among authors: sharp t. Neurochem Int. 1997 Sep;31(3):349-62. doi: 10.1016/s0197-0186(96)00106-4. Neurochem Int. 1997. PMID: 9246678

9

Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry.

Singewald N, Sharp T. Singewald N, et al. Among authors: sharp t. Neuroscience. 2000;98(4):759-70. doi: 10.1016/s0306-4522(00)00177-9. Neuroscience. 2000. PMID: 10891619

10

Genetic mouse models relevant to schizophrenia: taking stock and looking forward.

Harrison PJ, Pritchett D, Stumpenhorst K, Betts JF, Nissen W, Schweimer J, Lane T, Burnet PW, Lamsa KP, Sharp T, Bannerman DM, Tunbridge EM. Harrison PJ, et al. Among authors: sharp t. Neuropharmacology. 2012 Mar;62(3):1164-7. doi: 10.1016/j.neuropharm.2011.08.009. Epub 2011 Aug 16. Neuropharmacology. 2012. PMID: 21864547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

795 results

Search Page

Filters